{"id":157669,"date":"2025-11-01T20:48:13","date_gmt":"2025-11-01T20:48:13","guid":{"rendered":"https:\/\/www.europesays.com\/ie\/157669\/"},"modified":"2025-11-01T20:48:13","modified_gmt":"2025-11-01T20:48:13","slug":"highlights-from-global-cardio-oncology-summit-gc-os-2025-by-maria-sol-andres","status":"publish","type":"post","link":"https:\/\/www.europesays.com\/ie\/157669\/","title":{"rendered":"Highlights from Global Cardio-Oncology Summit (GC-OS) 2025 by Maria Sol Andres"},"content":{"rendered":"<p><strong> The Global Cardio-Oncology Summit (GCOS)<\/strong> is an annual international conference that unites experts in cardiology and oncology to advance the rapidly growing field of cardio-oncology. Organized by the <strong>International Cardio-Oncology Society<\/strong> (IC-OS), the summit highlights the latest research, clinical innovations, and collaborative efforts to prevent and manage heart complications related to cancer treatments. The 2025 summit was held from October 30 to November 1 in Cape Town, South Africa. It serves as a vital platform for healthcare professionals worldwide to improve outcomes for patients living with both cancer and cardiovascular disease.<\/p>\n<p>Maria Sol Andres, Clinical Research Fellow in Cardio-Oncology at Royal Brompton and Harefield hospitals, shared some key highlights from the Global Cardio-Oncology Summit 2025:<\/p>\n<p>\u201c<a href=\"https:\/\/www.linkedin.com\/posts\/mar%C3%ADa-sol-andr%C3%A9s-cardioonc_gcos2025-cardioonc-activity-7389614556286906368-dETB?utm_source=share&amp;utm_medium=member_desktop&amp;rcm=ACoAAEFHvEABUgX5NSeJGEx5I2xsrcujQ67sS1U\" target=\"_blank\" rel=\"noopener nofollow\"><strong>Wrapping up session 2<\/strong><\/a> \u2013 Day 1 of GCOS2025<\/p>\n<ol>\n<li>Cancer cells proliferate in unloaded hearts (can rhythmic mechanical stimulation reduce the tumour size? &gt; still early stage research<\/li>\n<li>Ferroptosis plays an important role in cardiotoxicity.<\/li>\n<li>NO IV IRON if patient is receiving ANTHRACYCLINES\u201d<\/li>\n<\/ol>\n<p><img loading=\"lazy\" decoding=\"async\" class=\"alignnone wp-image-401621\" src=\"https:\/\/www.europesays.com\/ie\/wp-content\/uploads\/2025\/11\/1761821400484.jpeg\" alt=\"Highlights from Global Cardio-Oncology Summit (GC-OS) 2025 by Maria Sol Andres\" width=\"692\" height=\"519\" title=\"Highlights from Global Cardio-Oncology Summit (GC-OS) 2025 by Maria Sol Andres 2\"  \/><\/p>\n<p>\u201cOngoing Keynote Lecture by Dr. <a href=\"https:\/\/www.linkedin.com\/posts\/mar%C3%ADa-sol-andr%C3%A9s-cardioonc_gcos2025-cardioonc-activity-7389672135805464576-OBpO?utm_source=share&amp;utm_medium=member_desktop&amp;rcm=ACoAAEFHvEABUgX5NSeJGEx5I2xsrcujQ67sS1U\" target=\"_blank\" rel=\"noopener nofollow\"><strong>Ruth Plummer<\/strong><\/a> GCOS2025<\/p>\n<p>\u2018<strong>Development of New Cancer Drugs \u2014 The Path to Clinic and Cardiotoxicity Monitoring\u2019<\/strong><br \/>1st \u2014 We \u2018grow up\u2019:<br \/><strong>The maximum tolerated dose is not always the optimal dose.<\/strong><br \/>2nd \u2014 We monitor \u2018obsessively\u2019:<br \/><strong>Close and continuous cardiac monitoring is essential.<\/strong><br \/>3rd \u2014 We grade:<br \/><strong>Every toxicity is tracked, evaluated, and learned from.<\/strong><\/p>\n<p>4th \u2014 We align:<\/p>\n<p>Following the ESC cardio-oncology guidelines ensures consistency and patient safety.<\/p>\n<p>What\u2019s New?<\/p>\n<p><strong>Antibody\u2013drug conjugates<\/strong> \u2013 targeted precision with powerful payloads Immunotherapy \u2014 including bispecifics that engage multiple immune pathways Genomic profiling \u2014 tailoring therapy through molecular insight<\/p>\n<p><strong>The Exciting Present and Future of Cancer Treatment<\/strong><\/p>\n<p>As innovation accelerates, let\u2019s make sure our patients\u2019 hearts can tolerate the thrill.\u201d<\/p>\n<p><img loading=\"lazy\" decoding=\"async\" class=\"alignnone wp-image-401626\" src=\"https:\/\/www.europesays.com\/ie\/wp-content\/uploads\/2025\/11\/1761835126375.jpeg\" alt=\"Highlights from Global Cardio-Oncology Summit (GC-OS) 2025 by Maria Sol Andres\" width=\"729\" height=\"547\" title=\"Highlights from Global Cardio-Oncology Summit (GC-OS) 2025 by Maria Sol Andres 3\"  \/><\/p>\n<p>\u201cPrimary care in CardioOncology \u2014 highlights from the great <a href=\"https:\/\/www.linkedin.com\/posts\/mar%C3%ADa-sol-andr%C3%A9s-cardioonc_cardioonc-activity-7389977668487892992-MaGy?utm_source=share&amp;utm_medium=member_desktop&amp;rcm=ACoAAEFHvEABUgX5NSeJGEx5I2xsrcujQ67sS1U\" target=\"_blank\" rel=\"noopener nofollow\"><strong>Siva Tharshini Ramalingam<\/strong><\/a><\/p>\n<p><strong>Key messages<\/strong><\/p>\n<ul>\n<li>Primary care physicians are the first point of contact for patients.<\/li>\n<li>Early recognition of cardiovascular (and systemic) side effects of cancer therapy =\u00a0education is essential.<\/li>\n<li>Diagnostic challenge: the therapy context changes the differential diagnosis.<\/li>\n<\/ul>\n<p>Dr. Ramalingam inspired us to become \u2018<strong>International Agents of Change<\/strong>.\u2019<\/p>\n<p>Challenge accepted!\u201d<\/p>\n<p><img loading=\"lazy\" decoding=\"async\" class=\"alignnone wp-image-401630\" src=\"https:\/\/www.europesays.com\/ie\/wp-content\/uploads\/2025\/11\/1761907973358.jpeg\" alt=\"Highlights from Global Cardio-Oncology Summit (GC-OS) 2025 by Maria Sol Andres\" width=\"733\" height=\"550\" title=\"Highlights from Global Cardio-Oncology Summit (GC-OS) 2025 by Maria Sol Andres 4\"  \/><\/p>\n<p>\u201c<a href=\"https:\/\/www.linkedin.com\/posts\/mar%C3%ADa-sol-andr%C3%A9s-cardioonc_cardiooncology-cardioonc-globalhealth-activity-7390030527052824578-nACK?utm_source=share&amp;utm_medium=member_desktop&amp;rcm=ACoAAEFHvEABUgX5NSeJGEx5I2xsrcujQ67sS1U\" target=\"_blank\" rel=\"noopener nofollow\">Global Cardio-Oncology Summit 2025<\/a><\/p>\n<p>CARDIO-ONCOLOGY across AFRICA<\/p>\n<p>Souhila Ouabdesselam (Algeria), Dr. Kieran Mwazo (Kenya), Nana Poku (Ghana \/ Switzerland), and Trishun Singh (South Africa) delivered insightful presentations on the current state of cardio-oncology in Africa.<\/p>\n<p><strong>Common Challenges<\/strong><\/p>\n<ul>\n<li>Transition from an infectious disease focus to long-term CVD and cancer care<\/li>\n<li>Limited resources for both treatment and prevention<\/li>\n<li>Inadequate specialist training in emerging fields<\/li>\n<li>Lack of standardised cardio-oncology programs across many regions<\/li>\n<\/ul>\n<p><strong>Opportunities and Next Steps<\/strong><\/p>\n<ul>\n<li>Strengthen preventive medicine and continuous education<\/li>\n<li>\u00a0Prioritize cardiovascular risk factor modification \u2014 going back to the basics<\/li>\n<li>Empower pharmacists as the first point of contact with patients<\/li>\n<li>Foster political will and stability for long-term strategy implementation<\/li>\n<\/ul>\n<p>With collaboration, education, and advocacy, the future of CardioOncology in Africa looks promising.\u201d<\/p>\n<p><img loading=\"lazy\" decoding=\"async\" class=\"alignnone wp-image-401636\" src=\"https:\/\/www.europesays.com\/ie\/wp-content\/uploads\/2025\/11\/1761920575375-1.jpeg\" alt=\"Highlights from Global Cardio-Oncology Summit (GC-OS) 2025 by Maria Sol Andres\" width=\"608\" height=\"456\" title=\"Highlights from Global Cardio-Oncology Summit (GC-OS) 2025 by Maria Sol Andres 5\"  \/><\/p>\n<p>\u201c<a href=\"https:\/\/www.linkedin.com\/posts\/mar%C3%ADa-sol-andr%C3%A9s-cardioonc_gcos2025-cardioonc-activity-7390332834068025345--EI4?utm_source=share&amp;utm_medium=member_desktop&amp;rcm=ACoAAEFHvEABUgX5NSeJGEx5I2xsrcujQ67sS1U\" target=\"_blank\" rel=\"noopener nofollow\">Venous Thromboembolism in Cancer Patients<\/a> \u2014 insights from Dr. <strong>Sebastian Szmit\u00a0<\/strong><\/p>\n<p>A key clinical question:<\/p>\n<p><strong>What should we do when lifelong or extended anticoagulation is required?<\/strong><\/p>\n<p>The API-CAT trial provides important evidence \u2014 showing that extended anticoagulation with a reduced dose of Apixaban is non-inferior to the full dose in preventing recurrent VTE.<\/p>\n<p>A step forward for personalised care in cardio-oncology and thrombosis management.\u201d<\/p>\n<p><img loading=\"lazy\" decoding=\"async\" class=\"alignnone wp-image-401640\" src=\"https:\/\/www.europesays.com\/ie\/wp-content\/uploads\/2025\/11\/1761992651744-e1762024882854.jpeg\" alt=\"Highlights from Global Cardio-Oncology Summit (GC-OS) 2025 by Maria Sol Andres\" width=\"659\" height=\"663\" title=\"Highlights from Global Cardio-Oncology Summit (GC-OS) 2025 by Maria Sol Andres 6\"  \/><\/p>\n<p>More posts from <a href=\"https:\/\/oncodaily.com\/tag\/global-cardio-oncology-summit-2025\" rel=\"nofollow noopener\" target=\"_blank\"><strong>Global Cardio-Oncology Summit.<\/strong><\/a><\/p>\n<p>\u00a0<\/p>\n","protected":false},"excerpt":{"rendered":"The Global Cardio-Oncology Summit (GCOS) is an annual international conference that unites experts in cardiology and oncology to&hellip;\n","protected":false},"author":2,"featured_media":157670,"comment_status":"","ping_status":"","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[78],"tags":[18,135,19,17],"class_list":{"0":"post-157669","1":"post","2":"type-post","3":"status-publish","4":"format-standard","5":"has-post-thumbnail","7":"category-health","8":"tag-eire","9":"tag-health","10":"tag-ie","11":"tag-ireland"},"share_on_mastodon":{"url":"https:\/\/pubeurope.com\/@ie\/115476411809040874","error":""},"_links":{"self":[{"href":"https:\/\/www.europesays.com\/ie\/wp-json\/wp\/v2\/posts\/157669","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.europesays.com\/ie\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.europesays.com\/ie\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.europesays.com\/ie\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.europesays.com\/ie\/wp-json\/wp\/v2\/comments?post=157669"}],"version-history":[{"count":0,"href":"https:\/\/www.europesays.com\/ie\/wp-json\/wp\/v2\/posts\/157669\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.europesays.com\/ie\/wp-json\/wp\/v2\/media\/157670"}],"wp:attachment":[{"href":"https:\/\/www.europesays.com\/ie\/wp-json\/wp\/v2\/media?parent=157669"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.europesays.com\/ie\/wp-json\/wp\/v2\/categories?post=157669"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.europesays.com\/ie\/wp-json\/wp\/v2\/tags?post=157669"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}